Mark Reynolds

1.6k total citations · 1 hit paper
23 papers, 924 citations indexed

About

Mark Reynolds is a scholar working on Ophthalmology, Neurology and Epidemiology. According to data from OpenAlex, Mark Reynolds has authored 23 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Ophthalmology, 5 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Mark Reynolds's work include Substance Abuse Treatment and Outcomes (5 papers), Traumatic Ocular and Foreign Body Injuries (4 papers) and Neuroblastoma Research and Treatments (3 papers). Mark Reynolds is often cited by papers focused on Substance Abuse Treatment and Outcomes (5 papers), Traumatic Ocular and Foreign Body Injuries (4 papers) and Neuroblastoma Research and Treatments (3 papers). Mark Reynolds collaborates with scholars based in United States, United Kingdom and Australia. Mark Reynolds's co-authors include Michael C. Cox, Steven G. DuBois, Theodore W. Laetsch, Alberto S. Pappo, Ramamoorthy Nagasubramanian, Leo Mascarenhas, Scott Cruickshank, Catherine M. Albert, Noah Federman and Jessica L. Davis and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Mark Reynolds

22 papers receiving 903 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

2018 378 citations Theodore W. Laetsch, Steven G. DuBois et al. The Lancet Oncology profile →

Peers

Mark Reynolds

PRM

ONCOL

NEURO

EPIDE

Alexander DeVries Austria

Lynne P. Taylor United States

Angela M. Feraco United States

Zarnie Lwin Australia

Lloyd United Kingdom

Arliene Ravelo United States

Jennifer Oliver United States

Jennifer Cullen United States

A O’Farrell Ireland

Clare Frobisher United Kingdom

Alexander DeVries Austria

Mark Reynolds

221 ×0.7

PRM

472 ×2.2

ONCOL

209 ×1.0

NEURO

105 ×0.6

316 ×1.7

EPIDE

Citations per year, relative to Mark Reynolds Mark Reynolds (= 1×) peers Alexander DeVries

Countries citing papers authored by Mark Reynolds

Since Specialization

Citations

This map shows the geographic impact of Mark Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Reynolds more than expected).

Fields of papers citing papers by Mark Reynolds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Reynolds. The network helps show where Mark Reynolds may publish in the future.

Co-authorship network of co-authors of Mark Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Reynolds. A scholar is included among the top collaborators of Mark Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Reynolds. Mark Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reynolds, Mark, et al.. (2022). Trend of Incidence of Ocular Injury in Service Members of the U.S. Armed Forces in 2016–2019. Ophthalmic Epidemiology. 30(4). 434–440. 3 indexed citations

Reynolds, Mark, et al.. (2021). Incidence of Optic Neuritis and the Associated Risk of Multiple Sclerosis for Service Members of U.S. Armed Forces. Military Medicine. 188(3-4). e697–e702. 4 indexed citations

Reynolds, Mark, et al.. (2019). Absolute and relative morbidity burdens attributable to ocular and vision-related conditions, active component, U.S. Armed Forces, 2018.. PubMed. 26(9). 4–11.

Reynolds, Mark, et al.. (2019). Incident and recurrent cases of central serous chorioretinopathy, active component, U.S. Armed Forces, 2001-2018.. PubMed. 26(9). 31–34. 1 indexed citations

Ziegler, David S., Marie Wong, Chelsea Mayoh, et al.. (2018). Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma. British Journal of Cancer. 119(6). 693–696. 81 indexed citations

Laetsch, Theodore W., Steven G. DuBois, Leo Mascarenhas, et al.. (2018). Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. The Lancet Oncology. 19(5). 705–714. 378 indexed citations breakdown →

DuBois, Steven G., Theodore W. Laetsch, Noah Federman, et al.. (2018). The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas. Cancer. 124(21). 4241–4247. 100 indexed citations

Reynolds, Mark, Robert A. Mazzoli, Marcus H. Colyer, et al.. (2017). Evaluation and Treatment of Ocular Injuries and Vision-Threatening Conditions in Prolonged Field Care. Journal of Special Operations Medicine. 17(4). 115–115. 3 indexed citations

Laetsch, Theodore W., Steven G. DuBois, Ramamoorthy Nagasubramanian, et al.. (2017). A pediatric phase I study of larotrectinib, a highly selective inhibitor of the tropomyosin receptor kinase (TRK) family.. Journal of Clinical Oncology. 35(15_suppl). 10510–10510. 6 indexed citations

10.

Drilon, Alexander, David S. Hong, John F. Deeken, et al.. (2016). A phase II basket study of the oral TRK inhibitor LOXO–101 in adult subjects with NTRK fusion-positive tumors. Annals of Oncology. 27. vi132–vi132. 4 indexed citations

11.

Blunt, Matthew D., Matthew Carter, Marta Larráyoz, et al.. (2015). The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model. Blood. 125(26). 4032–4041. 34 indexed citations

12.

Acevedo, Andrea, Deborah W. Garnick, Constance M. Horgan, et al.. (2015). Performance Measures and Racial/Ethnic Disparities in the Treatment of Substance Use Disorders. Journal of Studies on Alcohol and Drugs. 76(1). 57–67. 30 indexed citations

13.

Garfield, Sara, et al.. (2014). Erratum to: Measuring the severity of prescribing errors: A systematic review (Drug Safety (2013) 36, (1151-1157) DOI: 10.1007/s40264-013-0092-0). UCL Discovery (University College London). 8 indexed citations

14.

Lee, Margaret T., Constance M. Horgan, Deborah W. Garnick, et al.. (2014). A performance measure for continuity of care after detoxification: Relationship with outcomes. Journal of Substance Abuse Treatment. 47(2). 130–139. 34 indexed citations

15.

Garnick, Deborah W., Constance M. Horgan, Andrea Acevedo, et al.. (2013). Criminal justice outcomes after engagement in outpatient substance abuse treatment. Journal of Substance Abuse Treatment. 46(3). 295–305. 42 indexed citations

16.

Acevedo, Andrea, Deborah W. Garnick, Margaret T. Lee, et al.. (2012). Racial and Ethnic Differences in Substance Abuse Treatment Initiation and Engagement. Journal of Ethnicity in Substance Abuse. 11(1). 1–21. 68 indexed citations

17.

Reynolds, Mark, et al.. (2010). Helmet use and brain injury in motorcyclists in Florence, South Carolina.. PubMed. 106(5). 186–9. 1 indexed citations

18.

Cho, Raymond I., et al.. (2009). Concomitant Cranial and Ocular Combat Injuries During Operation Iraqi Freedom. The Journal of Trauma: Injury, Infection, and Critical Care. 67(3). 516–520. 21 indexed citations

19.

Garnick, Deborah W., Constance M. Horgan, Margaret T. Lee, et al.. (2007). Are Washington Circle performance measures associated with decreased criminal activity following treatment?. Journal of Substance Abuse Treatment. 33(4). 341–352. 55 indexed citations

20.

Hendryx, Michael, et al.. (2001). An Examination of Methods for Risk-Adjustment of Rehospitalization Rates. PubMed. 3(1). 15–24. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact